UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability

Leukemia, 2019-02, Vol.33 (2), p.457-468

2019

Volltextzugriff (PDF)

Expression of the chemokine receptor CCR1 promotes the dissemination of multiple myeloma plasma cells in vivo

Haematologica (Roma), 2021-12, Vol.106 (12), p.3176-3187

2021

Volltextzugriff (PDF)

GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice

PloS one, 2020-01, Vol.15 (1), p.e0228408-e0228408

2020

Volltextzugriff (PDF)

Clodronate-Liposome Mediated Macrophage Depletion Abrogates Multiple Myeloma Tumor Establishment In Vivo

Neoplasia (New York, N.Y.), 2019-08, Vol.21 (8), p.777-787

2019

Volltextzugriff (PDF)

A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome

Nature medicine, 2010-01, Vol.16 (1), p.59-66

2010

Volltextzugriff (PDF)

Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion

The Journal of experimental medicine, 2006-04, Vol.203 (4), p.1105-1116

2006

Volltextzugriff (PDF)

Twist-1 is upregulated by NSD2 and contributes to tumour dissemination and an epithelial-mesenchymal transition-like gene expression signature in t(4;14)-positive multiple myeloma

Cancer letters, 2020-04, Vol.475, p.99-108

2020

Volltextzugriff (PDF)

Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myeloma

British journal of haematology, 2023-11, Vol.203 (4), p.614-624

2023

Volltextzugriff (PDF)

HIF-2α Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12/CXCR4 and CCR1

Cancer research (Chicago, Ill.), 2017-10, Vol.77 (20), p.5452-5463

2017

Volltextzugriff (PDF)

Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines

Leukemia research, 2024-04, Vol.139, p.107469-107469, Article 107469

2024

Volltextzugriff (PDF)

DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment

Neoplasia (New York, N.Y.), 2017-12, Vol.19 (12), p.972-981

2017

Volltextzugriff (PDF)

Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myeloma

British journal of haematology, 2017-07, Vol.178 (2), p.196-208

2017

Volltextzugriff (PDF)

SAMSN1 Is a Tumor Suppressor Gene in Multiple Myeloma

Neoplasia (New York, N.Y.), 2014-07, Vol.16 (7), p.572-585

2014

Volltextzugriff (PDF)

Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress

Oncotarget, 2017-07, Vol.8 (27), p.43602-43616

2017

Volltextzugriff (PDF)

Dasatinib Cellular Uptake and Efflux in Chronic Myeloid Leukemia Cells: Therapeutic Implications

Clinical cancer research, 2008-06, Vol.14 (12), p.3881-3888

2008

Volltextzugriff (PDF)

Using genomics to better define high-risk MGUS/SMM patients

Oncotarget, 2018-11, Vol.9 (93), p.36549-36550

2018

Volltextzugriff (PDF)

Targeted Disruption of Bone Marrow Stromal Cell-Derived Gremlin1 Limits Multiple Myeloma Disease Progression In Vivo

Cancers, 2020-08, Vol.12 (8), p.2149

2020

Volltextzugriff (PDF)

Tetraspanin 7 (TSPAN7) expression is upregulated in multiple myeloma patients and inhibits myeloma tumour development in vivo

Experimental cell research, 2015-03, Vol.332 (1), p.24-38

2015

Volltextzugriff (PDF)

Characterization of the role of Samsn1 loss in multiple myeloma development

FASEB bioAdvances, 2020-09, Vol.2 (9), p.554-572

2020

Volltextzugriff (PDF)

PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma

Journal of hematology and oncology, 2015-10, Vol.8 (1), p.106-106, Article 106

2015

Volltextzugriff (PDF)

LCRF‐0006, a small molecule mimetic of the N‐cadherin antagonist peptide ADH‐1, synergistically increases multiple myeloma response to bortezomib

FASEB bioAdvances, 2020-06, Vol.2 (6), p.339-353

2020

Volltextzugriff (PDF)

Wrapping BCR-ABL: it's in the bag

Blood, 2010-11, Vol.116 (18), p.3382-3383

2010

Volltextzugriff (PDF)

Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome

Human molecular genetics, 2005-01, Vol.14 (2), p.335-346

2005

Volltextzugriff (PDF)

A Functional Genomic Screen to Identify Novel Genes Involved in Multiple Myeloma Tumour Development

Blood, 2023-11, Vol.142 (Supplement 1), p.1947-1947

2023

Volltextzugriff (PDF)

Targeted Inhibition of Myeloperoxidase (MPO): A New Therapeutic Strategy for the Treatment of Multiple Myeloma

Blood, 2023-11, Vol.142 (Supplement 1), p.3319-3319

2023

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(55)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability

Expression of the chemokine receptor CCR1 promotes the dissemination of multiple myeloma plasma cells in vivo

GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice

Clodronate-Liposome Mediated Macrophage Depletion Abrogates Multiple Myeloma Tumor Establishment In Vivo

A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome

Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion

Twist-1 is upregulated by NSD2 and contributes to tumour dissemination and an epithelial-mesenchymal transition-like gene expression signature in t(4;14)-positive multiple myeloma

Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myeloma

HIF-2α Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12/CXCR4 and CCR1

Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines

DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment

Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myeloma

SAMSN1 Is a Tumor Suppressor Gene in Multiple Myeloma

Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress

Dasatinib Cellular Uptake and Efflux in Chronic Myeloid Leukemia Cells: Therapeutic Implications

Using genomics to better define high-risk MGUS/SMM patients

Targeted Disruption of Bone Marrow Stromal Cell-Derived Gremlin1 Limits Multiple Myeloma Disease Progression In Vivo

Tetraspanin 7 (TSPAN7) expression is upregulated in multiple myeloma patients and inhibits myeloma tumour development in vivo

Characterization of the role of Samsn1 loss in multiple myeloma development

PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma

LCRF‐0006, a small molecule mimetic of the N‐cadherin antagonist peptide ADH‐1, synergistically increases multiple myeloma response to bortezomib

Wrapping BCR-ABL: it's in the bag

Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome

A Functional Genomic Screen to Identify Novel Genes Involved in Multiple Myeloma Tumour Development

Targeted Inhibition of Myeloperoxidase (MPO): A New Therapeutic Strategy for the Treatment of Multiple Myeloma

Suchergebnisse filtern